Back to Results
First PageMeta Content
Personalized medicine / Medicine / Asparaginase / Biology


Press Release ERYtech Pharma signs an agreement with M. D. Anderson Cancer Center to develop a companion test for GRASPA® in solid tumors th
Add to Reading List

Document Date: 2014-07-24 05:46:04


Open Document

File Size: 86,77 KB

Share Result on Facebook

City

Philadelphia / Lyon / Houston / /

Company

Press Release ERYtech Pharma / ERYtech Pharma ERYtech Pharma / M. D. Anderson Cancer Center / ERYtech Pharma / France ERYtech Pharma / /

Country

France / United States / /

/

Event

Business Partnership / /

IndustryTerm

therapeutic solutions / /

MedicalCondition

leukemia / cancer / metabolic diseases / solid tumors / /

MedicalTreatment

chemotherapy / /

Organization

Department of Bioinformatics / US Office / Philadelphia PA / /

Person

Philip Lorenzi / John Weinstein / Yann Godfrin / /

Position

Chair / Co-Founder and CEO / principal investigator / /

Technology

Bioinformatics / chemotherapy / /

URL

www.erytech.com / /

SocialTag